Stay updated on AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial
Sign up to get notified when there's something new on the AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial page.

Latest updates to the AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe record history now shows the addition of version v3.4.2 and the deletion of version v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedThe Record History now includes a new revision entry v3.4.1 and removes the previous v3.4.0 entry.SummaryDifference0.1%

- Check41 days agoChange DetectedA new revision v3.3.4 was added to the history and the previous revision v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedA new revision entry (v3.3.3) was added and older items ('HHS Vulnerability Disclosure' and 'Revision: v3.3.2') were removed.SummaryDifference0.2%

- Check91 days agoChange DetectedStudy Status and Recruitment Status were updated to show the trial is Completed, replacing the previous 'Active, not recruiting' status.SummaryDifference0.8%

- Check98 days agoChange DetectedThe notice about government funding and operating status at the top of the page has been removed. This change does not affect the study data or record availability. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

Stay in the know with updates to AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial page.